At the 2021 virtual congress, I was excited by select studies on emerging therapeutic approaches that remind us there is more to treating IBD than suppressing the immune system.
In this commentary, I present my take on interesting new data from the 2021 virtual Crohn’s & Colitis Congress on the relationship between visceral adipose tissue and outcomes for patients with IBD and the role of diet in IBD management.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.